These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7003611)

  • 1. Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients.
    Emrich HM; Zaudig M; Kissling W; Dirlich G; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):290-8. PubMed ID: 7003611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report.
    Tamminga CA; Tighe PJ; Chase TN; DeFraites EG; Schaffer MH
    Arch Gen Psychiatry; 1981 Feb; 38(2):167-8. PubMed ID: 7212942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia.
    Verhoeven WM; van Ree JM; Westenberg HG; Krul JM; Brouwer GJ; Thijssen JH; de Wied D; van Praag HM; Ceulemans DL; Kahn RS
    Psychiatry Res; 1984 Apr; 11(4):329-46. PubMed ID: 6204351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotic efficacy of neuroleptic neuropeptides in schizophrenia. Review of clinical data].
    Verhoeven VM
    Encephale; 1987; 13(6):349-56. PubMed ID: 2453339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indication of an antipsychotic action of the opiate antagonist naloxone.
    Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM; Westenberg HG; Gerritsen TW; van Praag HM; Thijssen JH; Schwarz F; van Ree JM; de Wied D
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients.
    Verhoeven WM; van Ree JM; Heezius-van Bentum A; de Wied D; van Praag HM
    Arch Gen Psychiatry; 1982 Jun; 39(6):648-54. PubMed ID: 7092498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
    Meltzer HY; Busch DA; Tricou BJ; Robertson A
    Psychiatry Res; 1982 Jun; 6(3):313-26. PubMed ID: 6125982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-lived effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
    Volavka J; Hui KS; Anderson B; Nemes Z; O'Donnell J; Lajtha A
    Psychiatry Res; 1983 Dec; 10(4):243-52. PubMed ID: 6583715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE).
    Verhoeven WM; van Praag HM; van Ree JM; de Wied D
    Arch Gen Psychiatry; 1979 Mar; 36(3):294-8. PubMed ID: 369471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of des-tyrosine-gamma-endorphin in tardive dyskinesia.
    Casey DE; Korsgaard S; Gerlach J; Jørgensen A; Simmelsgaard H
    Arch Gen Psychiatry; 1981 Feb; 38(2):158-60. PubMed ID: 7011248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of [Des-Tyr1]-gamma-endorphin in schizophrenia.
    Emrich HM; Zaudig M; v Zerssen D; Kissling W; Dirlich G; Herz A
    Mod Probl Pharmacopsychiatry; 1981; 17():279-86. PubMed ID: 7329421
    [No Abstract]   [Full Text] [Related]  

  • 19. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
    Whiteford HA; Stedman TJ; Welham J; Csernansky JG; Pond SM
    J Clin Psychopharmacol; 1992 Oct; 12(5):337-40. PubMed ID: 1362205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.